The draft guidance should clarify “remanufacturing” and recommendations for labeling devices intended to be serviced over their useful life. A discussion paper outlining cybersecurity challenges and opportunities with the servicing was also released.
FDA In Brief: FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices
More from FDA News AlertsMore posts in FDA News Alerts »
- FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes
- FDA In Brief: FDA Warns Firm with Over 15 Million Products Listed with FDA to Remove Unauthorized E-Cigarette Products from Market
- Coronavirus (COVID-19) Update: July 23, 2021
- Philips Respironics Recalls Certain Ventilators and BiPAP Machines Due to Potential Health Risks from PE-PUR Sound Abatement Foam